Bienvenido a Med Info Alert, el servicio de literatura científica de Boehringer Ingelheim que te permite estar al día de las publicaciones más recientes y relevantes sobre la enfermedad pulmonar intersticial difusa (EPID).
Si estás interesado en recibir alguna publicación de este mes, a continuación, puedes descargarla o acceder a tu cuenta para solicitarla.
¿También quieres estar actualizado los próximos meses con las publicaciones más recientes sobre EPID? Regístrate en avances en fibrosis pulmonar.
Rodríguez-Nieto MJ, et al. Economic Burden of Idiopathic Pulmonary Fibrosis in Spain: A Prospective Real-World Data Study (OASIS Study). Pharmacoeconomics. 2023
Ruaro B, et al. Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy. Pharmaceuticals (Basel). 2023
Štefániková M, et al. The effect of nintedanib on lung functions and survival in idiopathic pulmonary fibrosis: real-life analysis of the Czech EMPIRE registry. 2023
Kunihiro Y, et al. A quantitative analysis of long-term follow-up computed tomography of idiopathic pulmonary fibrosis: the correlation with the progression and prognosis. Acta Radiol. 2023
Dsouza KG, et al. Management of interstitial lung disease in patients with autoimmune disease-related interstitial lung disease. Multidiscip Respir Med. 2023
Matteson EL, et al. Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trial. Clin Rheumatol. 2023
Jones S, et al. Clinical trial simulations in pulmonary fibrosis: patient-focused insights and adaptations. ERJ Open Res. 2023
Denton CP, et al. Extent of fibrosis and lung function decline in patients with systemic sclerosis and interstitial lung disease: data from the SENSCIS trial. Rheumatology (Oxford). 2023
Pan L, et al. Nintedanib Ameliorates Bleomycin-Induced Pulmonary Fibrosis, Inflammation, Apoptosis, and Oxidative Stress by Modulating PI3K/Akt/mTOR Pathway in Mice. Inflammation. 2023
Alonso-Gonzalez A, et al. Idiopathic pulmonary fibrosis and the role of genetics in the era of precision medicine. Front Med (Lausanne). 2023
Smith DJF, et al. Contemporary Concise Review 2022: Interstitial lung disease. Respirology. 2023
Koudstaal T, et al. Idiopathic Pulmonary Fibrosis. Presse Med. 2023
PC-ES-111022